Yahya Daneshbod

SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

Marina K. Baine, Min‐Shu Hsieh, W. Victoria Lai et al. · Journal of Thoracic Oncology · 2020 · 468 citations · Full text

Immunogenetics, Sclc Subtypes, Histopathologic Characterization +10

Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes

Michael Offin, Joseph M. Chan, Megan Tenet et al. · Journal of Thoracic Oncology · 2019 · 428 citations · Full text

Tumor Biology, Medicine, Pathology +11

The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung Cancer

Adam J. Schoenfeld, Chai Bandlamudi, Jessica A. Lavery et al. · Clinical Cancer Research · 2020 · 265 citations · Full text

Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial

Mohammad Kazem Fallahzadeh, Banafshe Dormanesh, Mohammad Mahdi Sagheb et al. · American Journal of Kidney Diseases · 2012 · 135 citations

Renin-angiotensin System Inhibitors, Hypertension, Renal Function +9

Comparison of Conventional, Molecular, and Immunohistochemical Methods in Diagnosis of Typical and Atypical Cutaneous Leishmaniasis

Sadegh Shirian, Ahmad Oryan, Gholamreza Hatam et al. · Archives of Pathology & Laboratory Medicine · 2014 · 83 citations · Full text